Conivaptan: Evidence Supporting Its Therapeutic Use in Hyponatremia

Core Evidence - New Zealand
doi 10.2147/ce.s5997
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Conivaptan Bolus Dosing for the Correction of Hyponatremia in the Neurointensive Care Unit

Neurocritical Care
Critical CareNeurologyIntensive Care Medicine
2009English

Dose Comparison of Conivaptan (Vaprisol®) in Patients With Euvolemic or Hypervolemic Hyponatremia &Ndash; Efficacy, Safety, and Pharmacokinetics

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Eritoran: The Evidence of Its Therapeutic Potential in Sepsis

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Lixivaptan &Ndash; An Evidence-Based Review of Its Clinical Potential in the Treatment of Hyponatremia

Core Evidence
MedicineReviewsReferencesPharmacology
2013English

Hyponatremia Associated With Escitalopram Use in a Young Woman

Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
2011English

Supporting Evidence Use in Networked Professional Learning: The Role of the Middle Leader

Educational Research
Education
2017English

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension

Current Hypertension Reports
Internal Medicine
2016English

Panitumumab: The Evidence of Its Therapeutic Potential in Metastatic Colorectal Cancer Care

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Routine Use of Diuretics in Very-Low Birth-Weight Infants in the Absence of Supporting Evidence

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy